PRNewswire London [UK] Munich [Germany] New Delhi [India] January 22 Datar Cancer Genetics DCG today announced the launch of ...

Companion Cancer Diagnostics Market The rising incidence of cancer worldwide is a primary driver of the Global Companion Cancer Diagnostics ...

Researchers at The University of Hong Kong (HKU) have made an exciting discovery about how human cells protect DNA during ...

Researchers have made an exciting discovery about how human cells protect DNA during cell division, offering new insights into combating diseases such as cancer. The research uncovers the vital role ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

Image 1. PICH acts like a lookout, spotting and attaching to tiny DNA threads called ultrafine anaphase bridges (UFBs). When ...

VANCOUVER, BC, CANADA, January 20, 2025 /EINPresswire / -- The MRD Testing market is expected to grow from an estimated USD 1351.5 million in 2024 to USD 3901.1 million in 2033, at a CAGR of 12.50%.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

The genomic urine testing industry in the United States is predicted to reach USD 66.3 million by 2033, increasing at a 4.9% ...

A range of current precision oncology clinical trials are reliant on customized, targeted NGS-panel assays in order to ...

医疗团队透过基因密码，能够精准掌握并规画患者治疗计画，图为实验室示意照片。（高医提供／纪爰高雄传真） ...